The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study.
Kalliopi FoteinogiannopoulouKonstantinos KarmirisGeorgios AxiarisMagdalini VelegrakiAntonios GklavasChristina KapizioniCharalabos KarageorgosChristina KateriAnastasia KatsoulaGeorgios KokkotisEvgenia KouretaCharikleia LamouriPanagiotis MarkopoulosMaria PalatianouPloutarchos PastrasKonstantinos FasoulasOlga GioulemeEvanthia ZampeliAggeliki TheodoropoulouGeorgios TheocharisKonstantinos ThomopoulosPantelis KaratzasKonstantinos H KatsanosAndreas KapsoritakisAnastasia KourikouNikoleta MathouSpilios ManolakopoulosGeorgios MichalopoulosSpyridon MichopoulosAlexandros BoubonarisGiorgos BamiasVasileios PapadopoulosGeorge PapatheodoridisIoannis PapaconstantinouIoannis PachiadakisKonstantinos SouflerisMaria TzouvalaChristos TriantosEftychia TsironiDimitrios K ChristodoulouIoannis E Koutroubakisnull nullPublished in: BMC gastroenterology (2021)
The frequency of anemia in IBD patients, followed at Greek referral centers, is approximately 50%. Development of recurrent/persistent anemia may be observed in 20% of cases and is independently associated with the presence of extraintestinal manifestations, IBD duration, IBD related surgeries and hospitalizations. Anemia treatment is administered in up to [Formula: see text] of anemia IBD patients with the majority of them receiving iron intravenously.